CardioMEMS, Inc.

CardioMEMS, Inc. is a medical device company focused on developing and commercializing wireless sensing and communication technology for the human body. Founded in 2000, the company specializes in addressing severe chronic cardiovascular diseases, including heart failure, abdominal aortic aneurysms, and hypertension. Its innovative approach utilizes miniature wireless implantable sensors that provide continuous, real-time monitoring of critical cardiovascular parameters. Key products include the CardioMEMS Heart Failure Sensor, which monitors pulmonary artery pressure in heart failure patients, and the EndoSure Sensor, designed for monitoring blood pressure in patients with abdominal aortic aneurysms. Both products aim to enhance patient management and outcomes while reducing hospitalizations and healthcare costs. CardioMEMS' technology integrates MEMS fabrication with wireless communication, allowing for less invasive monitoring compared to traditional methods. The company serves cardiologists, vascular surgeons, and healthcare providers dedicated to managing chronic cardiovascular conditions.

• Employees 37
• Founded 2001
• Annual Revenue $16500000
• Total Funding $97881128